课题基金 / 基金详情

Characterizing the unique endocytic organelle of Trypanosoma cruzi

Characterizing the unique endocytic organelle of Trypanosoma cruzi
表征克氏锥虫独特的内吞细胞器
批准号:
9808880
负责人:
RONALD DREW ETHERIDGE
金额:
$18.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-21 至 2021-04-30

项目摘要

项目成果

RONALD DREW ETHERIDGE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The etiological agent of Chagas disease, Trypanosoma cruzi, is an obligate intracellular parasite that infects an estimated 10 million people in the Americas, with an at-risk population of 70 million. While the acute infection by the parasite is effectively controlled by the immune system, a chronic infection can persist for the lifetime of the host. Despite its recognition as the highest impact parasitic infection of the Americas, Chagas disease remains underreported, understudied and underfunded. Basic research into the biology of T. cruzi has been previously hindered by a lack of efficient genetic tools, but the advent of CRISPR/Cas9 gene editing technology has cleared the way for more in-depth molecular analyses. The primary interface between T. cruzi and its mammalian hosts is at the level of the replicative intracellular amastigotes in the cytoplasm of infected host cells. Trypanosoma cruzi is one of only a few protozoan pathogens that live and replicate directly in the cytosol of nucleated cells. Of the (mostly bacterial) pathogens that can inhabit the host cytosol, many have been shown to actively induce host cytosolic protein degradation in order to obtain energy and amino acids which are normally limiting in the cytoplasm. A long-standing mystery is how T. cruzi is able to extract necessary nutrients from this impoverished environment? Unlike other parasites, T. cruzi has the ability to endocytose and digest host cytosolic material via a long tubular invagination (cytopharynx) starting at a surface plasma membrane pore (cytostome). This structure, referred to here as the cytostome/cytopharynx or CSP complex, is present only in replicating forms of the T. cruzi and disassembles during the transition to trypomastigote stages. The CSP structure, which has been examined extensively using electron tomography techniques, has resisted molecular analysis, as the protein components comprising it have remained elusive. We have recently identified the first protein targeted solely to the CSP structure, CP1, and our preliminary work has shown that this protein colocalizes with endocytosed cargo in the CSP. In this proposal, we will use CP1 to carry out the first in-depth characterization of the T. cruzi CSP. We will fuse CP1 to the BioID biotin ligase and perform proximity labeling of the CSP to identify its protein components. A selected subset of the identified components will be validated by endogenous tagging and assessed for their role in parasite feeding, replication and survival. Additionally, we will extend our analysis of the host cell components taken up in the CSP to determine the selectively with respect to host proteins or organelles during intracellular amastigote replication. Completion of this study will allow us to begin analyzing in detail a unique, but crucial, aspect of T. cruzi parasitism which previously resisted in-depth investigation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the Mechanistic Basis for Phagotrophy in the Protozoan Trypanosoma cruzi (equipment supplement)
  • 批准号:
    10799091
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2022
  • 负责人:
    RONALD DREW ETHERIDGE
  • 依托单位:
Elucidating the Mechanistic Basis for Phagotrophy in the Protozoan Trypansoma cruzi
  • 批准号:
    10345248
  • 项目类别:
  • 资助金额:
    $30.2万
  • 财政年份:
    2022
  • 负责人:
    RONALD DREW ETHERIDGE
  • 依托单位:
Elucidating the Mechanistic Basis for Phagotrophy in the Protozoan Trypansoma cruzi
  • 批准号:
    10630908
  • 项目类别:
  • 资助金额:
    $30.2万
  • 财政年份:
    2022
  • 负责人:
    RONALD DREW ETHERIDGE
  • 依托单位:
Elucidating the Role of Endocytosis Via the Cytostome in the Life Cycle of Trypanosoma cruzi
  • 批准号:
    10414106
  • 项目类别:
  • 资助金额:
    $47.98万
  • 财政年份:
    2021
  • 负责人:
    RONALD DREW ETHERIDGE
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: